GlassScriptPhysician profile
Michael J Durkin
NPI 1215140892
$3,523.17
in general payments reported to CMS, 2019-2025
7 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,076 · 2020: $36.11 · 2021: $422 · 2022: $454 · 2023: $463 · 2024: $513 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,147.85 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $171.67 | 2023 | Linq II |
| United Therapeutics Corporation | $101.63 | 2019 | |
| Sanofi Pasteur INC. | $32.72 | 2025 | |
| Merck Sharp & Dohme LLC | $29.07 | 2023 | Gardasil 9 |
| Abbott Laboratories | $25.73 | 2019 | |
| Biotronik INC. | $14.50 | 2025 | Renamic Neo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Durkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.